142 related articles for article (PubMed ID: 37156046)
21. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.
Wang LM; Zhang LL; Wang LW; Zhu L; Ma XX
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10363-10369. PubMed ID: 31841190
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of m
Liu S; Li Q; Li G; Zhang Q; Zhuo L; Han X; Zhang M; Chen X; Pan T; Yan L; Jin T; Wang J; Lv Q; Sui X; Xie T
Cell Death Dis; 2020 Nov; 11(11):969. PubMed ID: 33177491
[TBL] [Abstract][Full Text] [Related]
23. MTA1 expression correlates significantly with cigarette smoke in non-small cell lung cancer.
Xu L; Mao XY; Fan CF; Zheng HC
Virchows Arch; 2011 Oct; 459(4):415-22. PubMed ID: 21892752
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
25. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1α expression in human non-small cell lung cancer cells.
Guo L; Li L; Wang W; Pan Z; Zhou Q; Wu Z
Biochim Biophys Acta; 2012 Jun; 1822(6):852-61. PubMed ID: 22349311
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC; Belisario DC; Akman M; La Vecchia S; Godel M; Anobile DP; Ortone G; Digiovanni S; Fontana S; Costamagna C; Rubinstein M; Kopecka J; Riganti C
J Exp Clin Cancer Res; 2022 Aug; 41(1):243. PubMed ID: 35953814
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
[TBL] [Abstract][Full Text] [Related]
29. Hydrogen sulfide modulates epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via HIF-1α activation.
Wang M; Yan J; Cao X; Hua P; Li Z
Biochem Pharmacol; 2020 Feb; 172():113775. PubMed ID: 31870768
[TBL] [Abstract][Full Text] [Related]
30. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
31. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
Wu S; Cheng Z; Yu L; Song W; Tao Y
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
[TBL] [Abstract][Full Text] [Related]
32. Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer.
Chen YQ; Zhao CL; Li W
J Exp Clin Cancer Res; 2009 Feb; 28(1):29. PubMed ID: 19245702
[TBL] [Abstract][Full Text] [Related]
33. IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway.
Xu L; Li K; Li J; Xu F; Liang S; Kong Y; Chen B
Epigenetics; 2023 Dec; 18(1):2265625. PubMed ID: 37871286
[No Abstract] [Full Text] [Related]
34. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
Yin X; Xia J; Sun Y; Zhang Z
BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
[TBL] [Abstract][Full Text] [Related]
35. Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation.
Kong P; Yu KN; Yang M; Almahi WA; Nie L; Chen G; Han W
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403326
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
37. Smoking-Induced M2-TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5-Regulated m6A Modification of SOCS2 in NSCLC Cells.
Cheng C; Wang P; Yang Y; Du X; Xia H; Liu J; Lu L; Wu H; Liu Q
Adv Sci (Weinh); 2023 Aug; 10(22):e2300953. PubMed ID: 37246269
[TBL] [Abstract][Full Text] [Related]
38. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
[TBL] [Abstract][Full Text] [Related]
39. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α.
Li X; Liu X; Xu Y; Liu J; Xie M; Ni W; Chen S
Int J Oncol; 2014 Oct; 45(4):1507-14. PubMed ID: 25051115
[TBL] [Abstract][Full Text] [Related]
40. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
